If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Director/PDMR Shareholding

22 Jun 2018 11:00

RNS Number : 2301S
Stenprop Limited
22 June 2018
 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

 

 

DEALINGS IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY OF THE COMPANY AND ISSUE OF NEW SHARES

 

 

22 June 2018

 

Shareholders are advised of the following information relating to the acceptance of market value options awarded on 7 June 2018 under the Stenprop Limited Long Term Incentive Plan ("Long Term Incentive Plan"). The market value options will vest in three tranches on 31 March 2019, 31 March 2020 and 31 March 2021 and once fully vested will result in the issue of 95 816 shares subject to the payment of the exercise price of £1.10 per share, for a deemed value of £105 397.60.

 

Name of director:

Name of subsidiary companies:

Nicolaas Marais

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

7 June 2018

Class of securities:

Market value options

Number of securities:

95 816

Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:

Off-market acceptance of market value options in terms of the Long Term Incentive Plan

Direct beneficial

Yes

 

Shareholders are further advised of the following information relating to the acceptance of nil cost options awarded on 7 June 2018 under the Stenprop Limited Amended Deferred Share Bonus Plan ("Deferred Bonus Plan"). One third of these nil cost options vested immediately, with the second third vesting on 31 March 2019 and the last third vesting on 31 March 2020. Once fully vested, they will result in the issue of 18 363 shares.

 

Name of director:

Name of subsidiary companies:

Nicolaas Marais

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

7 June 2018

Class of securities:

Nil cost options

Number of securities:

18 363

Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:

Off-market acceptance of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes

 

Shareholders are further advised of the exercise of nil cost options awarded under the Deferred Bonus Plan, comprising 6 121 nil cost options granted on 7 June 2018, which vested immediately, 3 675 options awarded on 8 June 2017 which vested on31 March 2018 and 5 283 options awarded on 9 June 2016 which vested on 31 March 2018, which will result in the issuance of 15 079 shares, in each case at a deemed value of £1.185 per share.

 

Name of director:

Name of subsidiary companies:

Nicolaas Marais

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

20 June 2018

Class of securities:

Nil cost options

Number of securities:

15 079

Deemed total value:

Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:

£17,868.61

Off-market exercise of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes

 

Following the transaction, Nicolaas Marais' beneficial interest in the Company is 295 679 shares, representing approximately 0.10% of the issued capital of the Company.

 

ISSUE OF NEW SHARES

 

Application has been made for 50 819 new ordinary shares to be admitted to the Specialist Fund Segment of the London Stock Exchange and to the Main Board of the JSE. This application includes the above 15 079 vested options exercised by Nicolaas Marais and an additional 35 740 ordinary shares in relation to the exercise of additional nil cost options by an employee of the Stenprop group in terms of the Deferred Bonus Plan. It is expected that admission will take place at 8.00 am on 26 June 2018.

 

 

 

Enquiries:

 

Stenprop Limited

Paul ArensonPatsy WatsonJulian Carey

+44(0)20 7079 6600

 

Numis Securities Limited (Financial Adviser)

Hugh JonathanVicki Paine

+44(0)20 7260 1000

 

Tavistock (PR adviser)

James Whitmore

James Verstringhe

Kirsty Allan

+44(0)20 7920 3150

 

JSE Sponsor

Java Capital Trustees and Sponsors Proprietary Limited

+ 27 (0) 11 722 3050

 

About Stenprop

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFKBDPOBKKFAB
Date   Source Headline
25th Aug 20107:00 amRNSAward of contract
2nd Jul 20101:12 pmRNSChange of Adviser Name
28th May 20107:00 amRNSAcquisition
26th Mar 20107:00 amRNSContract win
19th Mar 20107:00 amRNSAcquisition of Nessco Limited
11th Feb 20107:00 amRNSAcquisition
1st Feb 20107:00 amRNSAcquisition
29th Jan 20107:00 amRNSHalf Yearly Report
18th Dec 20097:00 amRNSFurther re Fundraising
23rd Nov 200912:21 pmRNSDirectorate Change
9th Nov 20099:08 amRNSAcquisition
3rd Nov 20097:00 amRNSFundraising and Acquisition
30th Oct 200911:46 amRNSResult of General Meeting and AGM
7th Oct 200912:35 pmRNSPosting of circular
1st Oct 20097:00 amRNSFinal Results
4th Aug 20093:38 pmRNSDirectorate Change
12th May 20097:00 amRNSContract Win and Trading Update
29th Jan 20097:00 amRNSContract Win
19th Jan 20097:00 amRNSHalf Yearly Report
6th Jan 20097:01 amRNSContract Win
6th Jan 20097:00 amRNSChange of Adviser
6th Nov 20087:00 amRNSDirector/PDMR Shareholding
5th Nov 20087:00 amRNSTrading Update
30th Oct 20087:00 amRNSNew Contract Win
21st Oct 20087:00 amRNSIssue of Equity, Debt Conversion
17th Oct 20087:00 amRNSIssue of Equity, Director/PDMR Holdings
15th Oct 20087:00 amRNSIndustry award for SpiriTel 118 service
29th Sep 20083:11 pmRNSResult of AGM
8th Sep 20089:08 amRNSAnnual Report and Accounts
26th Aug 20087:00 amRNSLong Term Incentive Plan
5th Aug 20087:00 amRNSAcquisition
31st Jul 20087:00 amRNSFinal Results
13th Jun 20083:28 pmRNSPrice Movement
6th Jun 20088:48 amRNSSpiritel Receive Double Award
22nd May 20081:08 pmRNSResult of EGM
7th May 200812:33 pmRNSGrant of options
30th Apr 20087:01 amRNSPublication of Circular
10th Apr 20082:34 pmRNSHolding(s) in Company
8th Apr 20087:02 amRNSDirector/PDMR Shareholding
3rd Apr 20087:01 amRNSAcquisition
28th Feb 20087:01 amRNSTrading Statement
25th Feb 20087:00 amRNSBalance Sheet Restructuring
31st Jan 20087:01 amRNSInterim Results
31st Jan 20087:00 amRNSChange of Adviser
25th Jan 200810:46 amRNSDirectorate Change
22nd Nov 200711:08 amRNSResult of AGM
15th Nov 20077:01 amRNSNew Contract
1st Nov 20077:01 amRNSAgreement with Virgin Mobile
30th Oct 20078:16 amRNSNotice of AGM
23rd Oct 20077:02 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.